Format

Send to:

Choose Destination
See comment in PubMed Commons below
N Am J Med Sci. 2012 Nov;4(11):537-47. doi: 10.4103/1947-2714.103312.

Newer antibacterials in therapy and clinical trials.

Author information

  • 1Consulting Medical Writer and Editor, India.

Abstract

In order to deal with the rising problem of antibiotic resistance, newer antibacterials are being discovered and added to existing pool. Since the year 2000, however, only four new classes of antibacterials have been discovered. These include the oxazolidinones, glycolipopeptides, glycolipodepepsipeptide and pleuromutilins. Newer drugs were added to existing classes of antibiotics, such as streptogramins, quinolones, beta-lactam antibiotics, and macrolide-, tetracycline- and trimethoprim-related drugs. Most of the antibacterials are directed against resistant S. aureus infections, with very few against resistant gram-negative infections. The following article reviews the antibacterials approved by the FDA after the year 2000 as well as some of those in clinical trials. Data was obtained through a literature search via Pubmed and google as well as a detailed search of our library database.

KEYWORDS:

Antibiotic resistance; Latest antibacterials; New antibacterials

PMID:
23181224
[PubMed]
PMCID:
PMC3503371
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
    Loading ...
    Write to the Help Desk